Left ventricular remodeling after late revascularization correlates with baseline viability

Tex Heart Inst J. 2014 Aug 1;41(4):381-8. doi: 10.14503/THIJ-13-3585. eCollection 2014 Aug.

Abstract

The ideal management of stable patients who present late after acute ST-elevation myocardial infarction (STEMI) is still a matter of conjecture. We hypothesized that the extent of improvement in left ventricular function after successful revascularization in this subset was related to the magnitude of viability in the infarct-related artery territory. However, few studies correlate the improvement of left ventricular function with the magnitude of residual viability in patients who undergo percutaneous coronary intervention in this setting. In 68 patients who presented later than 24 hours after a confirmed first STEMI, we performed resting, nitroglycerin-enhanced, technetium-99m sestamibi single-photon emission computed tomography-myocardial perfusion imaging (SPECT-MPI) before percutaneous coronary intervention, and again 6 months afterwards. Patients whose baseline viable myocardium in the infarct-related artery territory was more than 50%, 20% to 50%, and less than 20% were divided into Groups 1, 2, and 3 (mildly, moderately, and severely reduced viability, respectively). At follow-up, there was significant improvement in end-diastolic volume, end-systolic volume, and left ventricular ejection fraction in Groups 1 and 2, but not in Group 3. We conclude that even late revascularization of the infarct-related artery yields significant improvement in left ventricular remodeling. In patients with more than 20% viable myocardium in the infarct-related artery territory, the extent of improvement in left ventricular function depends upon the amount of viable myocardium present. The SPECT-MPI can be used as a guide for choosing patients for revascularization.

Keywords: Comparative study; infarct-related artery territory; left ventricular remodeling; myocardial infarction, acute ST-elevation/therapy; myocardial reperfusion; percutaneous coronary intervention; prospective studies; residual viability; technetium Tc 99m sestamibi/diagnostic use; time factors; tissue survival; tomography, emission-computed, single-photon; ventricular function, left.

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy*
  • Myocardial Perfusion Imaging / methods
  • Myocardial Revascularization*
  • Patient Selection
  • Predictive Value of Tests
  • Radiopharmaceuticals
  • Recovery of Function
  • Severity of Illness Index
  • Stroke Volume
  • Technetium Tc 99m Sestamibi
  • Time Factors
  • Time-to-Treatment*
  • Tissue Survival
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome
  • Ventricular Function, Left*
  • Ventricular Remodeling*

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi